JP2005504029A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504029A5 JP2005504029A5 JP2003515240A JP2003515240A JP2005504029A5 JP 2005504029 A5 JP2005504029 A5 JP 2005504029A5 JP 2003515240 A JP2003515240 A JP 2003515240A JP 2003515240 A JP2003515240 A JP 2003515240A JP 2005504029 A5 JP2005504029 A5 JP 2005504029A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxybenzylamino
- diphenylmethyl
- azabicyclo
- octane
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30669201P | 2001-07-20 | 2001-07-20 | |
| PCT/IB2002/002847 WO2003009848A1 (en) | 2001-07-20 | 2002-07-15 | Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005504029A JP2005504029A (ja) | 2005-02-10 |
| JP2005504029A5 true JP2005504029A5 (cg-RX-API-DMAC10.html) | 2005-09-22 |
Family
ID=23186426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003515240A Withdrawn JP2005504029A (ja) | 2001-07-20 | 2002-07-15 | 犬の好ましくない行動を改善するためのｎｋ−１受容体アンタゴニストの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20030139443A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1411946A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2005504029A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20040029375A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1529600A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2448722A1 (cg-RX-API-DMAC10.html) |
| CZ (1) | CZ200434A3 (cg-RX-API-DMAC10.html) |
| HU (1) | HUP0401154A2 (cg-RX-API-DMAC10.html) |
| IL (1) | IL158990A0 (cg-RX-API-DMAC10.html) |
| PL (1) | PL367944A1 (cg-RX-API-DMAC10.html) |
| SK (1) | SK252004A3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2003009848A1 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA200308991B (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0507325A (pt) * | 2004-01-30 | 2007-07-03 | Pfizer Prod Inc | antagonistas dos receptores nk-1 para melhorar a recuperação da anestesia |
| HUE034099T2 (en) | 2004-01-30 | 2018-01-29 | Zoetis Services Llc | Antimicrobial preservatives for the delivery of multidose formulations using beta-cyclodextrins for liquid dosage forms |
| CN1972937A (zh) * | 2004-04-30 | 2007-05-30 | 先灵公司 | 神经肽受体调节剂 |
| CN114403042A (zh) * | 2021-12-13 | 2022-04-29 | 深圳先进技术研究院 | 一种大动物焦虑症动物模型 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
| US5232929A (en) * | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
| FR2677361A1 (fr) * | 1991-06-04 | 1992-12-11 | Adir | Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| BR9206073A (pt) * | 1991-05-31 | 1994-12-06 | Pfizer | Derivados de quinuclidina |
| SK282203B6 (sk) * | 1991-06-20 | 2001-12-03 | Pfizer Inc. | Fluoroalkoxybenzylamínové deriváty heterocyklov obsahujúcich dusík, spôsob ich prípravy, medziprodukty, spôsob prípravy medziproduktov, použitie a farmaceutický prostriedok |
| EP0687268B1 (en) * | 1993-03-04 | 1998-05-27 | Pfizer Inc. | Spiroazacyclic derivatives as substance p antagonists |
| EP0623344B1 (fr) * | 1993-05-04 | 2000-07-26 | Ceva Sante Animale | Utilisation de la Sélégiline en médecine vetérinaire |
| IL109646A0 (en) * | 1993-05-19 | 1994-08-26 | Pfizer | Heteroatom substituted alkyl benzylamino-quinuclidines |
| US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
| US5703065A (en) * | 1993-09-17 | 1997-12-30 | Pfizer Inc. | Heteroarylamino and heteroarylsulfonamido substituted 3-benyzlaminomethyl piperidines and related compounds |
| US6083943A (en) * | 1993-09-17 | 2000-07-04 | Pfizer Inc | Substituted azaheterocyclecarboxylic acid |
| US5854262A (en) * | 1993-10-07 | 1998-12-29 | Pfizer Inc. | Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists |
| PE45195A1 (es) * | 1994-03-03 | 1996-01-17 | Boehringer Ingelheim Kg | Derivado de aminoacido, procedimiento para su preparacion y composicion farmaceutica que lo contiene |
| US5607936A (en) * | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
| ES2229259T3 (es) * | 1995-01-12 | 2005-04-16 | Glaxo Group Limited | Derivados de piperidina con actividad antagonista de taquiquinina. |
| US5990125A (en) * | 1996-01-19 | 1999-11-23 | Pfizer Inc. | NK-1 receptor antagonists for the treatment of cancer |
| US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| AU726745B2 (en) * | 1996-10-07 | 2000-11-16 | Merck Sharp & Dohme Limited | CNS-penetrant NK-1 receptor antagonists as antidepressant and/or an anti-anxiety agent |
| CA2275527C (en) * | 1996-12-19 | 2003-09-23 | Hoechst Marion Roussel, Inc. | Novel heterocyclic substituted pyrrolidine amide derivatives |
| US6156749A (en) * | 1997-12-01 | 2000-12-05 | Merck Sharp & Dohme Limited | Use of NK-1 receptor antagonists for treating movement disorders |
| JP4669095B2 (ja) * | 1999-07-19 | 2011-04-13 | 太陽化学株式会社 | ペットの問題行動抑制組成物 |
| CA2280309C (en) * | 1999-08-13 | 2007-05-08 | William Norton Milgram | Use of adrafinil to treat behavioral problems in aged canines |
| CA2324813A1 (en) * | 1999-11-10 | 2001-05-10 | Susan Beth Sobolov-Jaynes | Combination treatment for depression and anxiety |
| US20020049211A1 (en) * | 2000-09-06 | 2002-04-25 | Sobolov-Jaynes Susan Beth | Combination treatment for depression and anxiety |
-
2002
- 2002-07-15 EP EP02745741A patent/EP1411946A1/en not_active Withdrawn
- 2002-07-15 SK SK25-2004A patent/SK252004A3/sk not_active Application Discontinuation
- 2002-07-15 PL PL02367944A patent/PL367944A1/xx not_active Application Discontinuation
- 2002-07-15 JP JP2003515240A patent/JP2005504029A/ja not_active Withdrawn
- 2002-07-15 WO PCT/IB2002/002847 patent/WO2003009848A1/en not_active Ceased
- 2002-07-15 HU HU0401154A patent/HUP0401154A2/hu unknown
- 2002-07-15 CA CA002448722A patent/CA2448722A1/en not_active Abandoned
- 2002-07-15 CN CNA028141873A patent/CN1529600A/zh active Pending
- 2002-07-15 IL IL15899002A patent/IL158990A0/xx unknown
- 2002-07-15 KR KR10-2004-7000901A patent/KR20040029375A/ko not_active Ceased
- 2002-07-15 CZ CZ200434A patent/CZ200434A3/cs unknown
- 2002-07-19 US US10/199,284 patent/US20030139443A1/en not_active Abandoned
-
2003
- 2003-11-19 ZA ZA200308991A patent/ZA200308991B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960021024A (ko) | 구토 치료를 위한 nk-1 수용체 길항제 및 5ht₃수용체 길항제 | |
| Zajecka | {Clinical Issues in Long-Term Treatment With Antidepressants | |
| HUP0302044A2 (hu) | Egy CB1 receptor antagonista és sibutramin kombinációja, ezt tartalmazó gyógyászati készítmények és alkalmazásuk elhízás kezelésére | |
| JP2008545647A5 (cg-RX-API-DMAC10.html) | ||
| CA2458855A1 (en) | Composition for treating parkinson's disease containing a cb1 receptor antagonist and a product activating dopaminergic neurotransmission in the brain | |
| KR20210107729A (ko) | 운동 장애의 치료 | |
| Kamerling et al. | Dose related effects of the kappa agonist U‐50, 488H on behaviour, nociception and autonomic response in the horse | |
| JP2003012557A (ja) | 不安及びうつ病のための多剤併用治療 | |
| RU2004101278A (ru) | Композиция, включающая ингибитор pde-4 и антагонист h1-рецептора и ее применение для получения лекарственного препарата для лечения респираторных заболеваний | |
| JP2013536206A5 (cg-RX-API-DMAC10.html) | ||
| JP7588773B2 (ja) | グルタミン酸２ｂ受容体拮抗薬及びシグマ受容体作動薬の鎮咳薬としての使用 | |
| US20030139443A1 (en) | Use of tachykinin antagonists, including NK-1 receptor antagonists, to modify unwanted behavior in dogs, cats and horses | |
| RU2005135649A (ru) | Комбинации пароксетина и 4-(s)-(4-ацетилпиперазин-1-ил)-2-(r)-(4-фтор-2-метилфенил)пиперидин-1-карбоновой кислоты [1-(r)-(3, 5-бис-трифторметилфенил)этил]метиламида для лечения депрессии и/или тревоги | |
| Ferraro et al. | Evaluation of three chemical immobilization protocols in golden‐headed lion tamarins (Leontopithecus chrysomelas) undergoing vasectomy surgery | |
| JP2004513924A (ja) | 組み合わせた５−ｈｔ１ａアゴニストおよびセロトニン再取り込み阻害剤の新規な使用 | |
| KR20230159526A (ko) | 타시피미딘 제형 및 이의 용도 | |
| JP2024541315A (ja) | 中枢性低換気に関連する状態を治療するための方法および組成物 | |
| JP4387102B2 (ja) | 糖尿病性神経障害及び片頭痛の治療のためのチアガビンの使用 | |
| Carter | Benefits of medicating patients for veterinary visits | |
| Friton et al. | Investigation of the clinical efficacy, safety and palatability of meloxicam (Metacam®) treatment in horses with musculosceletal disorders | |
| AU2002317436A1 (en) | Use of NK-1 receptor antagonists to modify unwanted behaviour in dogs, cats and horses | |
| EP1505976B1 (en) | Synergistic combination of an opioid analgesic and a nsaid | |
| McLeod | The Welfare Concerns of Heritable Dental Diseases | |
| JP2002501046A5 (cg-RX-API-DMAC10.html) | ||
| CN116916909A (zh) | 用于治疗睡眠呼吸暂停的瑞波西汀和毒蕈碱受体拮抗剂(mra)的组合 |